Page 47 - Read Online

Borek et al. Rare Dis Orphan Drugs J 2023;2:5 https://dx.doi.org/10.20517/rdodj.2022.20 Page 11 of 14

Am J Physiol Lung Cell Mol Physiol 2018;315:L977-90. DOI PubMed PMC
34. Qiu H, He Y, Ouyang F, Jiang P, Guo S, Guo Y. The role of regulatory T cells in pulmonary arterial hypertension. J Am Heart Assoc
2019;8:e014201. DOI PubMed PMC
35. Jandl K, Marsh LM, Mutgan AC, et al. Impairment of the NKT-STAT1-CXCL9 axis contributes to vessel fibrosis in pulmonary
hypertension caused by lung fibrosis. Am J Respir Crit Care Med 2022;206:981-98. DOI PubMed
36. Koudstaal T, van Hulst JAC, Das T, et al. DNGR1-Cre-mediated deletion of Tnfaip3/A20 in conventional dendritic cells induces
pulmonary hypertension in mice. Am J Respir Cell Mol Biol 2020;63:665-80. DOI PubMed
37. Savai R, Pullamsetti SS, Kolbe J, et al. Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial
hypertension. Am J Respir Crit Care Med 2012;186:897-908. DOI PubMed
38. Ucero AC, Bakiri L, Roediger B, et al. Fra-2-expressing macrophages promote lung fibrosis in mice. J Clin Invest 2019;129:3293-
309. DOI PubMed PMC
39. Florentin J, Coppin E, Vasamsetti SB, et al. Inflammatory macrophage expansion in pulmonary hypertension depends upon
mobilization of blood-borne monocytes. J Immunol 2018;200:3612-25. DOI PubMed PMC
40. Özpelit E, Akdeniz B, Özpelit ME, et al. Prognostic value of neutrophil-to-lymphocyte ratio in pulmonary arterial hypertension. J Int
Med Res 2015;43:661-71. DOI PubMed
41. Harbaum L, Baaske KM, Simon M, et al. Exploratory analysis of the neutrophil to lymphocyte ratio in patients with pulmonary
arterial hypertension. BMC Pulm Med 2017;17:72. DOI PubMed PMC
42. Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science 2004;303:1532-5. DOI PubMed
43. Phillipson M, Kubes P. The neutrophil in vascular inflammation. Nat Med 2011;17:1381-90. DOI PubMed PMC
44. Galiè N, Palazzini M, Manes A. Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-
analyses. Eur Heart J 2010;31:2080-6. DOI PubMed PMC
45. Korkmaz B, Horwitz MS, Jenne DE, Gauthier F. Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human
diseases. Pharmacol Rev 2010;62:726-59. DOI PubMed PMC
46. Pham CT. Neutrophil serine proteases fine-tune the inflammatory response. Int J Biochem Cell Biol 2008;40:1317-33. DOI PubMed
PMC
47. Cowland JB, Borregaard N. The individual regulation of granule protein mRNA levels during neutrophil maturation explains the
heterogeneity of neutrophil granules. J Leukoc Biol 1999;66:989-95. DOI PubMed
48. Adkison AM, Raptis SZ, Kelley DG, Pham CT. Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the
development of acute experimental arthritis. J Clin Invest 2002;109:363-71. DOI PubMed PMC
49. Tkalcevic J, Novelli M, Phylactides M, Iredale JP, Segal AW, Roes J. Impaired immunity and enhanced resistance to endotoxin in the
absence of neutrophil elastase and cathepsin G. Immunity 2000;12:201-10. DOI PubMed
50. Kim YM, Haghighat L, Spiekerkoetter E, et al. Neutrophil elastase is produced by pulmonary artery smooth muscle cells and is
linked to neointimal lesions. Am J Pathol 2011;179:1560-72. DOI PubMed PMC
51. Dollery CM, Owen CA, Sukhova GK, Krettek A, Shapiro SD, Libby P. Neutrophil elastase in human atherosclerotic plaques:
production by macrophages. Circulation 2003;107:2829-36. DOI PubMed
52. Rose F, Hattar K, Gakisch S, et al. Increased neutrophil mediator release in patients with pulmonary hypertension--suppression by
inhaled iloprost. Thromb Haemost 2003;90:1141-9. DOI PubMed
53. Sweatt AJ, Miyagawa K, Rhodes CJ, et al. Severe pulmonary arterial hypertension is characterized by increased neutrophil elastase
and relative elafin deficiency. Chest 2021;160:1442-58. DOI PubMed PMC
54. Jandl K, Marsh LM, Hoffmann J, et al. Basement membrane remodeling controls endothelial function in idiopathic pulmonary
arterial hypertension. Am J Respir Cell Mol Biol 2020;63:104-17. DOI PubMed
55. Thompson K, Rabinovitch M. Exogenous leukocyte and endogenous elastases can mediate mitogenic activity in pulmonary artery
smooth muscle cells by release of extracellular matrix-bound basic fibroblast growth factor. J Cell Physiol 1996;166:495-505. DOI
PubMed
56. Senior RM, Griffin GL, Mecham RP. Chemotactic activity of elastin-derived peptides. J Clin Invest 1980;66:859-62. DOI PubMed
PMC
57. Zhu Y, Huang Y, Ji Q, et al. Interplay between Extracellular Matrix and Neutrophils in Diseases. J Immunol Res 2021;2021:8243378.
DOI PubMed PMC
58. Geraghty P, Rogan MP, Greene CM, et al. Neutrophil elastase up-regulates cathepsin B and matrix metalloprotease-2 expression. J
Immunol 2007;178:5871-8. DOI PubMed
59. Pham CT. Neutrophil serine proteases: specific regulators of inflammation. Nat Rev Immunol 2006;6:541-50. DOI PubMed
60. Standish AJ, Weiser JN. Human neutrophils kill Streptococcus pneumoniae via serine proteases. J Immunol 2009;183:2602-9. DOI
PubMed
61. Clancy DM, Sullivan GP, Moran HBT, et al. Extracellular neutrophil proteases are efficient regulators of IL-1, IL-33, and IL-36
cytokine activity but poor effectors of microbial killing. Cell Rep 2018;22:2937-50. DOI PubMed
62. Fukuta T, Okada H, Takemura G, et al. Neutrophil elastase inhibition ameliorates endotoxin-induced myocardial injury
accompanying degradation of cardiac capillary glycocalyx. Shock 2020;54:386-93. DOI PubMed PMC
63. Suzuki K, Okada H, Takemura G, et al. Neutrophil elastase damages the pulmonary endothelial glycocalyx in lipopolysaccharide-
induced experimental endotoxemia. Am J Pathol 2019;189:1526-35. DOI PubMed